From DCAT Value Chain Insights (VCI)
Catalent Pharma Solutions has appointed Sally Langa to the position of vice president, business development, for Catalent’s Development and Analytical Services offerings. In this role, Ms. Langa will be responsible for growing Catalent’s early-phase development business for small-molecule compounds, including analytical services, formulation development, and micronization.
Ms. Langa joins Catalent from Halo Pharma where she held the role of vice president, sales and marketing. Her career within the pharmaceutical services industry, which spans almost 30 years, has also seen her hold a number of senior positions at Patheon.
Source: Catalent Pharma Solutions
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription